Home > News > Content
Introduction Of LGD 4033
Oct 15, 2018

LGD-4033, commonly known as Anabolicum, is a selective androgen receptor modulator (SARM), similar to testosterone, which is anabolic, but does not clearly show its effects outside of muscle tissue.

The LGD-4033 signature prosthesis is a SARM that binds tightly to androgen receptors, primarily receptors for muscle and bone. Attached to the androgen receptor, it produces enhanced anabolic activity (muscle formation) in the body and is also shown to be resistant to catabolism (muscle consumption). Studies have shown that the anatomical chamber has a significant effect on bone degradation through strengthening. Unlike anabolic steroids attached to androgen receptors, its muscle structure and skeletal strengthening properties do not exhibit any activity outside the target muscle and body skeletal regions, at least to a minimum.

LGD 4033

The effects of LGD-4033 on flukes range from expansion and cutting to whole body transformation. Since SARM is still relatively new in the market, it is difficult to compare the power of LGD-4033 with various anabolic steroids, but the effect seems obvious. In the off-season or obese athletes can expect to gain significant strength and muscle mass with enough calories. They will also find that water retention does not occur, which means that any added weight is the weight of lean muscle tissue. One of the most important problems for athletes who are dieting or dieting is how to protect their muscles. When you want to lose weight, you must consume more calories than you consume, and this will cause muscle tissue to be lost without protective substances. Regardless of how good a person's genes are, the loss of some muscle tissue is inevitable. Muscle tissue can be preserved by increasing anabolic activity, such as attaching an effective SARM to the body. This will result in a tighter, thinner, harder and more muscular physique.

Some data, although preliminary at this stage, have shown the impact of LGD-4033, and to some extent may promote fat reduction. Increased muscle endurance has also been reported, especially when superimposed with other muscle endurance. It is unclear how much the impact of LGD-4033 alone on endurance. Side effects of LGD-4033 appear to be small and often do not exist in many users. Unlike the anabolic steroids that promote large amounts of androgenic activity, this associated negative effect does not seem to exist in most cases. The side effects of LGD-4033 are possible, but they are also very rare, making it one of the ideal projects in the performance-enhancing arsenal. The side effects of estrogen do not include the nature of any estrogen, making water retention, bloating, male breast disease and high blood pressure associated with water retention impossible. LGD-4033 does not promote aromatization, the conversion of testosterone to estrogen. Anti-estrogen is not required to use this SARM. Androgen-derived: Despite binding to the androgen receptor, the target area is still muscle and bone. Acne and alopecia cannot occur with this SARM. Testosterone inhibition: Testosterone inhibition is possible, but should not be as important as inhibition associated with anabolic steroid use. Some people claim that suppression is suppression, no matter what the rate, but at best it is simplistic. A person's natural testosterone levels are 650 ng/dl, which is suppressed to 450 ng/dl, which is a far cry from 42 ng/dl. More importantly, the data show that both luteinizing hormone (LH) and follicle stimulating hormone (FSH) will remain in their current state. Some data also show a slight decrease in sex hormone binding globulin (SHBG), which in turn may increase free testosterone levels. However, a significant increase in free testosterone is not possible. Post-cycle treatment (PCT) medication may or may not be dependent on the individual, but usually requires a period of normalization. Hepatotoxicity: Although oral, LGD-4033 is not toxic to the liver and has no effect on liver enzymes. This product is not a C17-alpha alkylated (C17-aa) or methylated drug. Anabolicum manages the half-life of Anabolicum (LGD-4033) for approximately 30 hours, preferably once a day. 10 mg per day is the most common dose.